Results 51 to 60 of about 719,957 (193)

Pulmonary Mucormycosis with Endobronchial Involvement Complicated by Pleural Effusion. [PDF]

open access: yesJ Clin Pract Res
Background: Pulmonary mucormycosis is an infection caused by a fungus with a severe and often fatal course, with a mortality rate exceeding 50%. It can spread through blood or lymphatic fluids or by inhalation of sporangiospores.
Rabahoğlu B   +4 more
europepmc   +2 more sources

A Concise Review on Mucormycosis [PDF]

open access: yes, 2022
Mucormycosis is a serious life-threatening angioinvasive infection caused due to mucormycosis. It is a very rare disease but occurs in patients who are immunocompromised which is because of neutropenia, diabetic ketoacidosis, increase serum level of ...
Vaishali D. Naphade   +4 more
core   +1 more source

Recurrent pulmonary mucormycosis after lobectomy in a non-smoking patient without predisposing risk factors

open access: yesBrazilian Journal of Infectious Diseases, 2012
Pulmonary mucormycosis is a very rare clinical condition in patients without underlying risk factors. A limited number of cases have been reported in predominantly elderly patients; history of smoking appears to be a common feature. A case of non-smoking
Lu Zhang   +4 more
doaj   +1 more source

Ravulizumab Shows Favorable Survival and Improves Clinical Markers in Children With HSCT‐TMA: Results of a Phase 3 Trial

open access: yesAmerican Journal of Hematology, EarlyView.
Pediatric HSCT‐TMA: Results of a global Phase 3 trial of ravulizumab. ABSTRACT Hematopoietic stem cell transplantation‐associated thrombotic microangiopathy (HSCT‐TMA) is a rare, life‐threatening complication that can lead to multiorgan failure and death.
Franco Locatelli   +15 more
wiley   +1 more source

The Black Fungus: A Rare Case of Pulmonary Mucormycosis. [PDF]

open access: yesHCA Healthc J Med
BACKGROUND: Mucormycosis, commonly known as the “black fungus,” is a severe infection affecting multiple organ systems, including the skin, brain, lungs, and gastrointestinal tract.
Wong S   +4 more
europepmc   +2 more sources

A rare case of post-COVID mucormycosis of the kidney

open access: yesCurrent Medicine Research and Practice, 2022
Post-COVID mucormycosis of the kidney is a rare phenomenon with only very few cases reported, worldwide. Among the various opportunistic fungal infections, mucormycosis is associated with the highest mortality.
Ankit Tyagi   +3 more
doaj   +1 more source

Dual biologic therapy in inflammatory bowel disease, a retrospective cohort study of vedolizumab and anti‐tumor necrosis factor alpha therapy in children

open access: yesJournal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives Despite advances in pediatric inflammatory bowel disease (PIBD) with biologics, remission rates remain at 47%–60% with loss‐of‐response rates at 60%–68%. Evidence for efficacy of dual biologic therapy (DBT) with anti‐tumor necrosis factor alpha therapy (anti‐TNF‐α)‐ vedolizumab (VDZ) for children refractory to anti‐TNF‐α therapy is ...
Jonathan E. M. O'Donnell   +6 more
wiley   +1 more source

AN OVERVIEW OF MUCORMYCOSIS [PDF]

open access: yes, 2022
Mucormycosis is an angioinvasive infection caused by Zygomycosis in the order of Mucorales. It is mainly affected in immunocompromised individuals followed by risk factors such as diabetes mellitus, stem cell transplantation, organ transplantation ...
PICHAIVEL, MANIMEKALAI   +3 more
core   +1 more source

Mixed Invasive Fungal Pneumonia Caused by Aspergillus, Candida, Mucor in an Immunocompromised Host

open access: yesRespirology Case Reports, Volume 14, Issue 11, November 2026.
We report a case of mixed invasive fungal pneumonia caused by Aspergillus, Candida and Mucor species in an immunocompromised host, highlighting the diagnostic and therapeutic implications of concurrent opportunistic fungal infections. ABSTRACT Invasive fungal pneumonia (IFP) is a life‐threatening complication in immunocompromised patients, particularly
Taeyun Kim   +6 more
wiley   +1 more source

Spontaneous regression of pulmonary mucormycosis [PDF]

open access: yesPostgraduate Medical Journal, 1995
Abstract A case of pulmonary mucormycosis with spontaneous resolution is presented. The patient had no known underlying predisposing disease.
P, Abraham   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy